Related Experiment Video
Updated: Jun 24, 2026

10:58
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Prion protein peptides as vaccines
M Ghielmetti1, T Vranac, V Curin Serbec
1Department for the Production of Diagnostic Reagents and Research, Blood Transfusion Centre of Slovenia, Slajmerjeva 6, 1000 Ljubljana, Slovenia.
Mini Reviews in Medicinal Chemistry
|April 10, 2009
Summary
Prion protein peptide immunizations are being investigated to find ways to combat disease-causing prions. This research identifies the most immunogenic prion protein segments for therapeutic development.
Area of Science:
- Neuroscience
- Immunology
- Protein Chemistry
Background:
- Prion diseases involve a misfolded protein isoform that is difficult to target.
- Developing therapies requires understanding the prion protein's immunogenic properties.
- Distinguishing between pathological and cellular prion proteins is crucial for safe treatment.
Purpose of the Study:
- To identify the most immunogenic peptides of the prion protein.
- To guide the development of targeted prion disease therapies.
- To summarize existing research on prion protein peptide immunizations.
Main Methods:
- Review of studies utilizing prion protein peptides for immunization.
- Analysis of immune responses generated by different prion protein peptide sequences.
- Identification of specific peptide regions eliciting significant immunogenicity.
Main Results:
- Certain prion protein peptide fragments were found to be highly immunogenic.
- These immunogenic regions are key targets for therapeutic antibody development.
- The findings highlight specific epitopes responsible for immune recognition.
Conclusions:
- Targeting specific immunogenic peptides offers a promising strategy against prion diseases.
- Further research can leverage these findings to create effective prion-targeting treatments.
- Understanding prion protein immunogenicity is vital for advancing prion disease research.
Related Concept Videos
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

